It suppresses the TGF-β ligand–receptor interactions [208], and TGF-β signaling, controlling a various group of cellular mechanisms in cancer, including cell proliferation, differentiation and apoptosis, as well as morin [189,208,210]. The gene discussed is TGFB1; the disease is cancer.